305 related articles for article (PubMed ID: 17330626)
1. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea.
Wolf JE; Del Rosso JQ
Cutis; 2007 Jan; 79(1):73-80. PubMed ID: 17330626
[TBL] [Abstract][Full Text] [Related]
2. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
Del Rosso JQ
Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
[TBL] [Abstract][Full Text] [Related]
4. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
[TBL] [Abstract][Full Text] [Related]
5. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
[TBL] [Abstract][Full Text] [Related]
6. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
Wolf JE; Kerrouche N; Arsonnaud S
Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
[TBL] [Abstract][Full Text] [Related]
8. An update on the role of topical metronidazole in rosacea.
Zip C
Skin Therapy Lett; 2006 Mar; 11(2):1-4. PubMed ID: 16598386
[TBL] [Abstract][Full Text] [Related]
9. Topical metronidazole therapy for rosacea.
Bleicher PA; Charles JH; Sober AJ
Arch Dermatol; 1987 May; 123(5):609-14. PubMed ID: 2953312
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
[TBL] [Abstract][Full Text] [Related]
11. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
Fowler JF
J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530
[TBL] [Abstract][Full Text] [Related]
12. Dapsone Gel in the Treatment of Papulopustular Rosacea: A Double-Blind Randomized Clinical Trial.
Faghihi G; Khosravani P; Nilforoushzadeh MA; Hosseini SM; Assaf F; Zeinali N; Smiley A
J Drugs Dermatol; 2015 Jun; 14(6):602-6. PubMed ID: 26091386
[TBL] [Abstract][Full Text] [Related]
13. Azelaic acid 15% gel: in the treatment of papulopustular rosacea.
Frampton JE; Wagstaff AJ
Am J Clin Dermatol; 2004; 5(1):57-64. PubMed ID: 14979745
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
[TBL] [Abstract][Full Text] [Related]
15. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study.
Koçak M; Yağli S; Vahapoğlu G; Ekşioğlu M
Dermatology; 2002; 205(3):265-70. PubMed ID: 12399675
[TBL] [Abstract][Full Text] [Related]
16. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.
Moore A; Kempers S; Murakawa G; Weiss J; Tauscher A; Swinyer L; Liu H; Leoni M
J Drugs Dermatol; 2014 Jan; 13(1):56-61. PubMed ID: 24385120
[TBL] [Abstract][Full Text] [Related]
18. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
Laquieze S; Czernielewski J; Baltas E
J Dermatolog Treat; 2007; 18(3):158-62. PubMed ID: 17538804
[TBL] [Abstract][Full Text] [Related]
19. Adapalene vs. metronidazole gel for the treatment of rosacea.
Altinyazar HC; Koca R; Tekin NS; Eştürk E
Int J Dermatol; 2005 Mar; 44(3):252-5. PubMed ID: 15807740
[TBL] [Abstract][Full Text] [Related]
20. [Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea].
Espagne E; Guillaume JC; Archimbaud A; Baspeyras M; Boitier F; Bussière M; Chamberlin J; Coin A; Di Crescenzo MC; Dolivo M
Ann Dermatol Venereol; 1993; 120(2):129-33. PubMed ID: 8240534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
